Benefits of Autoantibody Enrichment in Early Rheumatoid Arthritis: Analysis of Efficacy Outcomes in Four Pooled Abatacept Trials
ConclusionsThis analysis, including large patient numbers of early-RA abatacept trials, confirmed beneficial treatment effects of abatacept in patients with SPEAR versus non-SPEAR.
Source: Rheumatology and Therapy - Category: Rheumatology Source Type: research
More News: Abatacept | Arthritis | Methotrexate | Orencia | Rheumatoid Arthritis | Rheumatology | Study